UCN and nonpapillary renal cell carcinoma: Furthermore, UCN knockdown significantly suppressed tumor growth and synergized with PD-1 blockade to enhance antitumor efficacy (<i>p</i> < 0.001).<h4>Conclusions</h4>The IMI is a robust tool for risk stratification in ccRCC.